Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue–Related Raynaud Phenomenon in the United States
There are advances in outcome measures for quantifying pain now available for RP clinical trials. Large US-based registries for systemic sclerosis using patient-reported outcomes can allow serial data collection on RP and RP-related digital lesions to provide real-world data on medication efficacy for pain relief.
Authors
- Justin S. Baba (ORCID: https://orcid.org/0000-0003-2574-4279)
- Andrew L. Sternlicht
- W. David Merryman (ORCID: https://orcid.org/0000-0001-9662-1503)
- Tracy Frech (ORCID: https://orcid.org/0000-0002-5472-3840)
- Charles G Frech
Institutions
- Tufts University (US)
- Vanderbilt University (US)
- VA Tennessee Valley Healthcare System (US)
- Vanderbilt Health (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1002/acr.25660
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00